Recent Patents on Anti-Cancer Drug Discovery

Papers
(The TQCC of Recent Patents on Anti-Cancer Drug Discovery is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Acknowledgement to Contributors33
Acknowledgement to Reviewers27
Current Prospects for Adrenocortical Carcinoma Pharmacotherapy26
Comprehensive Genomic Analysis of Puerarin in Inhibiting Bladder Urothelial Carcinoma Cell Proliferation and Migration21
Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies20
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer20
Interplay between RNA Methylation Eraser FTO and Writer METTL3 in Renal Clear Cell Carcinoma Patient Survival20
N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer17
Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta- Analysis and Systematic Review16
Research Progress on the Anticancer Activity of Plant Polysaccharides16
Patent Selections15
Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer14
Protective Assessment of Novel (Bncs Formulation) against Brain Tumor14
Nanomaterials for Diagnosis and Treatment of Lung Cancer: A Review of Recent Patents14
The Prognostic Role of Interferon Gamma-inducible Protein 30 in Clear Cell Renal Cell Carcinoma with Immune Infiltrates14
The Present State and Potential Applications of Artificial Intelligence in Cancer Diagnosis and Treatment13
The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking13
Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer13
Santacruzamate A Compositions, Analogs and Methods of Use: A Patent Evaluation of WO 2014/018913 (A2)13
Radiotherapy Enhancing and Radioprotective Properties of Berberine: A Systematic Review13
The Application of Nanotechnology in Immunotherapy based Combinations for Cancer Treatment13
Cancer Immunotherapy - Immune Checkpoint Inhibitors in Hepatocellular Carcinoma12
Network Pharmacology-based Prediction and Verification of Shikonin for Treating Colorectal Cancer12
Current Status and Future Perspectives on Old Drug Repurposing for Cancer Treatment12
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder Cancer12
USP31 Activates the Wnt/β-catenin Signaling Pathway and Promotes Gastric Cancer Cell Proliferation, Invasion and Migration11
Acknowledgement To Reviewers11
Regulating Lipid Metabolism via Mitochondrial Dynamics in Tongue Squamous Cell Carcinoma Cancer Stem Cells11
Alpha-solanine Anti-tumor Effects in Non-small Cell Lung Cancer Through Regulating the Energy Metabolism Pathway11
Bourgeoning Cancer Targets10
Vitexin’s Role in Colon Cancer Apoptosis: AMPK/mTOR Pathway Modulation Explored Through Experimental and Computational Approaches10
The Causal Effects of Cholelithiasis on Acute Pancreatitis and Pancreatic Cancer: A Large Sample Size Mendelian Randomization Analysis10
Bioinformatics Analysis of Key Genes Associated with Resistance to the Combination of Bevacizumab and Pemetrexed Chemotherapy in Non-small Cell Lung Cancer10
Survival Benefits of Ganoderma Lucidum in Early-stage Triple-negative Breast Cancer: A Real World Study10
Self-immolative Linkers in Prodrugs and Antibody Drug Conjugates in Cancer Treatment10
Integrated Single-cell and Bulk RNA Sequencing Analysis Cross Talk between Ferroptosis-related Genes and Prognosis in Oral Cavity Squamous Cell Carcinoma9
Mechanisms of Anti-PD Therapy Resistance in Digestive System Neoplasms9
STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells9
Reposition of the Fungicide Ciclopirox for Cancer Treatment9
Recent Trend for EGFR-Based and ALK-Based Targets: A Patent Analysis8
Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database8
Patent Selections8
Antioxidant, Anti-Inflammatory and Anticancer Activities of the Methanolic Extract of Thottea siliquosa: An In Vitro and In Silico Study8
Prospective Challenges for Patenting and Clinical Trials of Anticancer Compounds from Natural Products: Coherent Review8
Current Status and Prospects of Camrelizumab, A Humanized Antibody Against Programmed Cell Death Receptor 18
Screening of Candidate Inflammatory Markers of Epithelial Cells in Hepatocellular Carcinoma Based on Integration Analysis of TCGA/ICGC Databases and Single-cell Sequencing8
lncRNA H22954 Inhibits Angiogenesis in Acute Myeloid Leukemia through a PDGFA-dependent Mechanism7
Patent Selections7
The m6A Reader IGF2BP2 Promotes Oral Squamous Cell Carcinoma Progression by Maintaining UCA1 Stability7
Meet the Editorial Board Member7
Ubiquitination-related Gene UBTD1 Mediates Poor Prognosis of Colorectal Cancer and Affects Colorectal Cancer Cell Proliferation and Ferroptosis7
Puerarin: An Anticancer and Anti-Inflammatory Agent7
Targeting the Key Signaling Pathways in Breast Cancer: From Molecular Mechanism to Therapeutic Interventions7
SSPH I, A Novel Anti-cancer Saponin, Inhibits EMT and Invasion and Migration of NSCLC by Suppressing MAPK/ERK1/2 and PI3K/AKT/ mTOR Signaling Pathways7
Intracholecystic Papillary-tubular Neoplasm (ICPN) of the Gallbladder: A Case Report Focusing on an Unexpected Pathological Finding7
Construction and Identification of a Human Colorectal Adenoma Epithelial Cell Line by SV40 Large T-Antigen Transfection7
Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer7
Circular RNA NF1-419 Inhibits Proliferation and Induces Apoptosis by Regulating Lipid Metabolism in Astroglioma Cells7
Metallodrugs as Anticancer Chemotherapeutics and Diagnostic Agents: A Critical Patent Review (2010-2020)6
Patent Selections6
Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug 6
Prognostic and Therapeutic Values of Autophagy-related Genes in Triple-negative Breast Cancer6
Application of Nano Drug Delivery System (NDDS) in Cancer Therapy: A Perspective6
The FJQR Has Synergistic Effect with Fluoropyrimidine in the Maintenance Treatment for HER-2 Negative Gastric Cancer6
Fatty Acid Synthase (FASN): A Patent Review Since 2016-Present6
Preface6
Natural STAT3 Inhibitors for Cancer Treatment: A Comprehensive Literature Review6
The Synergistic Effect of Ruthenium Complex Δ-Ru1 and Doxorubicin in a Mouse Breast Cancer Model6
Advances in the Treatment of Chronic Myeloid Leukemia6
Combining PD-1 Inhibitor with VEGF/VEGFR2 Inhibitor in Chemotherapy: Report of a Patient with End-Stage Cholangiocarcinoma and Review of Literature5
UBE2L3 Suppresses Oxidative Stress-regulated Necroptosis to Accelerate Osteosarcoma Progression5
Investigating the Therapeutic Potential and Molecular Mechanisms of Daphnetin: A Comprehensive Review5
Adverse Effects of Gefitinib on Skin and Colon in a Lung Cancer Mouse Model5
Recent Patent-Based Perspective on Diagnostic and Therapeutic Interventions in Malignant Mesothelioma: Is Drug Repositioning Knocking on the Door?5
Immunological Mechanism and Clinical Application of PAMP Adjuvants5
Exploring the Anticancer Potentials of Polyphenols: A Comprehensive Review of Patents in the Last Five Years5
Patent Selections5
A Synergistic Combination of Oleanolic Acid and Apatinib to Enhance Antitumor Effect on Liver Cancer Cells and Protect against Hepatic Injury5
0.081548929214478